Skip to main content
Fig. 6 | Cancer Nanotechnology

Fig. 6

From: Construction of pH-responsive nanocarriers in combination with ferroptosis and chemotherapy for treatment of hepatocellular carcinoma

Fig. 6

A CLSM images of ROSs production in MHCC-97 h, HepG2, SMMC-7721 and SK-Hep1 cells. B FCM assays. C MDA content production and D WB analysis the expression of GPX4 after MHCC-97 h cells were treated with PBS, HMPB, SO and HP/SO/CS for 24 h. *p < 0.5, and ***p < 0.001. E–F Bio-TEM imaging after MHCC-97 h cells were treated with PBS and HP/SO/CS for 24 h

Back to article page